Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance NASDAQ PIRS opened at $0.28 on Friday. The company has a 50 day simple moving average of $0.29 and a 200-day simple […]

Leave a Reply

Your email address will not be published.

Previous post SuperCom (NASDAQ:SPCB) Earns Sell Rating from Analysts at StockNews.com
Next post MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com